IMARC Group, a leading market research company, has recently released a report titled "In-Vitro Diagnostics Packaging Market Report by Product (Bottles and Vials, Tubes, Petri Dishes, Closures, and Others), Application (Diabetes, Infectious Diseases, Cardiology, Autoimmune Diseases, Oncology, Drug Testing, and Others), and Region 2025-2033." The study provides a detailed analysis of the industry, including the global in-vitro diagnostics packaging market size, share, trends, growth and forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

In-Vitro Diagnostics Packaging Market Overview:

The global in-vitro diagnostics packaging market size reached USD 8.7 Billion in 2024. It is projected to reach USD 12.5 Billion by 2033, growing at a CAGR of 3.85% during the forecast period of 2025-2033. Growth is driven by the rising prevalence of chronic diseases such as cancer and diabetes, increased focus on patient safety, and growing demand for home healthcare and self-testing solutions.

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

In-Vitro Diagnostics Packaging Market Key Takeaways

• Current Market Size: USD 8.7 Billion (2024)
• CAGR: 3.85%
• Forecast Period: 2025-2033
• Stringent regulatory compliance alongside advancements in diagnostic techniques is propelling market growth.
• North America dominates the market due to expanding manufacturing facilities and rising demand for point-of-care testing devices.
• The Asia Pacific region is a key market driven by rising in-vitro diagnostics test demand among patients.
• Market players are investing in capacity expansion and introducing compact in-vitro diagnostics packaging solutions.
• Challenges include maintaining regulatory compliance while opportunities arise from the need for eco-friendly packaging materials.

Request Your Free “In-Vitro Diagnostics Packaging Market” Insights Sample PDF: https://www.imarcgroup.com/in-vitro-diagnostics-packaging-market/requestsample

Market Growth Factors

Chronic diseases are increasingly common so in-vitro diagnostics packaging is in demand. In 2021, the American Cancer Society reported 608,570 cancer deaths throughout the United States. Inactive lives, bad food intake, and no exercise, with the growth of cities, have made cancer, diabetes, and autoimmune diseases more common. In-vitro diagnostic tests are important for people, especially as the population continues to age. As a result, there is a growing demand for safe and secure packaging solutions for samples.

Patient safety and convenience are important aspects of growth. Packaging, in the in-vitro diagnostics market, is used to safely store, transport, and handle the product, protecting it from contamination and from the spread of harmful germs. The use of vials prevents excessive handling and potential contamination of the sample. Improvements in productivity on filling lines and patient safety have been developed, such as SGD Pharma's Type I tubular vial with Velocity Vial coating. Furthermore, a rise in healthcare spending coupled with improved patient outcomes increases the packaging market.

The market is driven by the growing trend towards homecare and self-testing and the growing demand for lightweight, tamper-obvious user-friendly packages with chemical resistance, durability, transparency and low cost. The use of in-vitro diagnostics kits in home care for testing is growing. For example, NeoDx Biotech Labs manufactures a line of test kits for the identification of autoimmune disorders. Demand for packaging designed for healthcare at the end-user level, outside the healthcare environment, is driven by the trend toward home health care and portable testing.

Market Segmentation

Breakup by Product:

• Bottles and Vials
• Tubes
• Petri Dishes
• Closures
• Others

Breakup by Product:

• Diabetes
• Infectious Diseases
• Cardiology
• Autoimmune Diseases
• Oncology
• Drug Testing
• Others

Breakup By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America dominates the in-vitro diagnostics packaging market, holding the largest market share. Growth is supported by expanding manufacturing capacities and infrastructure, as evidenced by Bormioli Pharma's 47% sales increase in North America in 2023. The region benefits from strong regulatory frameworks and rising demand for point-of-care testing devices, making it a key player in market revenue generation.

Recent Developments & News

• On 11 December 2023, Thermo Fisher Scientific Inc launched the KingFisher Apex Dx automated nucleic acid purification instrument and the Applied Biosystems MagMAX Dx Viral or Pathogen NA Isolation Kit for respiratory specimen pathogen isolation. These products feature REACH-compliant and ethically sourced packaging.
• On 12 May 2021, Amcor introduced Dessiflex packaging technology integrating desiccants into sealant layers, eliminating the need for extra moisture protection.
• On 25 May 2021, Stevanato Group entered a licensing agreement with Corning Incorporated to offer combined solutions enhancing injectable drug protection with Corning Valor RTU Vials featuring SG EZ-fill technology.

Key Players

• SGD Pharma
• Corning Incorporated
• NeoDx Biotech Labs
• Bormioli Pharma
• Thermo Fisher Scientific
• Amcor
• Stevanato Group

Ask Analyst For Request Customization: https://www.imarcgroup.com/request?type=report&id=902&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302